230 related articles for article (PubMed ID: 32669468)
1. Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins.
Minoni L; Romero-Medina MC; Venuti A; Sirand C; Robitaille A; Altamura G; Le Calvez-Kelm F; Viarisio D; Zanier K; Müller M; Accardi R; Tommasino M
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669468
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of transforming properties of E6 and E7 from different beta human papillomavirus types.
Cornet I; Bouvard V; Campo MS; Thomas M; Banks L; Gissmann L; Lamartine J; Sylla BS; Accardi R; Tommasino M
J Virol; 2012 Feb; 86(4):2366-70. PubMed ID: 22171257
[TBL] [Abstract][Full Text] [Related]
3. Modulation of microRNA-mRNA Target Pairs by Human Papillomavirus 16 Oncoproteins.
Harden ME; Prasad N; Griffiths A; Munger K
mBio; 2017 Jan; 8(1):. PubMed ID: 28049151
[TBL] [Abstract][Full Text] [Related]
4. Identification of miRNAs dysregulated in human foreskin keratinocytes (HFKs) expressing the human papillomavirus (HPV) Type 16 E6 and E7 oncoproteins.
Yablonska S; Hoskins EE; Wells SI; Khan SA
Microrna; 2013; 2(1):2-13. PubMed ID: 25070710
[TBL] [Abstract][Full Text] [Related]
5. UV Radiation Activates Toll-Like Receptor 9 Expression in Primary Human Keratinocytes, an Event Inhibited by Human Papillomavirus 38 E6 and E7 Oncoproteins.
Pacini L; Ceraolo MG; Venuti A; Melita G; Hasan UA; Accardi R; Tommasino M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724760
[TBL] [Abstract][Full Text] [Related]
6. Different HPV16 E6/E7 oncogene expression patterns in epithelia reconstructed from HPV16-immortalized human endocervical cells and genital keratinocytes.
Sun Q; Tang SC; Pater MM; Pater A
Oncogene; 1997 Nov; 15(20):2399-408. PubMed ID: 9395236
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.
Gandhi S; Nor Rashid N; Mohamad Razif MF; Othman S
Mol Biol Rep; 2021 Jun; 48(6):5121-5133. PubMed ID: 34169395
[TBL] [Abstract][Full Text] [Related]
8. Transcription Properties of Beta-HPV8 and HPV38 Genomes in Human Keratinocytes.
Rehm TM; Straub E; Forchhammer S; Leiter U; Iftner T; Stubenrauch F
J Virol; 2022 Dec; 96(23):e0149822. PubMed ID: 36394329
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus type 16 E6 and E7 oncoproteins interact with the nuclear p53-binding protein 1 in an in vitro reconstructed 3D epithelium: new insights for the virus-induced DNA damage response.
Squarzanti DF; Sorrentino R; Landini MM; Chiesa A; Pinato S; Rocchio F; Mattii M; Penengo L; Azzimonti B
Virol J; 2018 Nov; 15(1):176. PubMed ID: 30445982
[TBL] [Abstract][Full Text] [Related]
10. High-Risk Mucosal Human Papillomavirus 16 (HPV16) E6 Protein and Cutaneous HPV5 and HPV8 E6 Proteins Employ Distinct Strategies To Interfere with Interferon Regulatory Factor 3-Mediated Beta Interferon Expression.
Poirson J; Suarez IP; Straub ML; Cousido-Siah A; Peixoto P; Hervouet E; Foster A; Mitschler A; Mukobo N; Chebaro Y; Garcin D; Recberlik S; Gaiddon C; Altschuh D; Nominé Y; Podjarny A; Trave G; Masson M
J Virol; 2022 May; 96(10):e0187521. PubMed ID: 35475668
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
[TBL] [Abstract][Full Text] [Related]
12. Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV).
Lim J; Lilie H; Kalbacher H; Roos N; Frecot DI; Feige M; Conrady M; Votteler T; Cousido-Siah A; Corradini Bartoli G; Iftner T; Trave G; Simon C
J Biol Chem; 2023 Aug; 299(8):104954. PubMed ID: 37354975
[TBL] [Abstract][Full Text] [Related]
13. The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.
Caldeira S; Zehbe I; Accardi R; Malanchi I; Dong W; Giarrè M; de Villiers EM; Filotico R; Boukamp P; Tommasino M
J Virol; 2003 Feb; 77(3):2195-206. PubMed ID: 12525654
[TBL] [Abstract][Full Text] [Related]
14. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
[TBL] [Abstract][Full Text] [Related]
15. A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.
Jönsson J; Wang L; Kajitani N; Schwartz S
Nucleic Acids Res; 2024 Jan; 52(1):316-336. PubMed ID: 37994701
[TBL] [Abstract][Full Text] [Related]
16. Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.
Schütze DM; Snijders PJ; Bosch L; Kramer D; Meijer CJ; Steenbergen RD
J Virol; 2014 Feb; 88(3):1714-24. PubMed ID: 24257607
[TBL] [Abstract][Full Text] [Related]
17. E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer development.
Mansour M; Touka M; Hasan U; Bellopede A; Smet A; Accardi R; Gabet AS; Sylla BS; Tommasino M
Virology; 2007 Oct; 367(1):1-9. PubMed ID: 17568647
[TBL] [Abstract][Full Text] [Related]
18. E6 and E7 from beta HPV38 cooperate with ultraviolet light in the development of actinic keratosis-like lesions and squamous cell carcinoma in mice.
Viarisio D; Mueller-Decker K; Kloz U; Aengeneyndt B; Kopp-Schneider A; Gröne HJ; Gheit T; Flechtenmacher C; Gissmann L; Tommasino M
PLoS Pathog; 2011 Jul; 7(7):e1002125. PubMed ID: 21779166
[TBL] [Abstract][Full Text] [Related]
19. Roles of the PDZ domain-binding motif of the human papillomavirus type 16 E6 on the immortalization and differentiation of primary human foreskin keratinocytes.
Choi M; Lee S; Choi T; Lee C
Virus Genes; 2014 Apr; 48(2):224-32. PubMed ID: 24293186
[TBL] [Abstract][Full Text] [Related]
20. Development of DNA Vaccine Targeting E6 and E7 Proteins of Human Papillomavirus 16 (HPV16) and HPV18 for Immunotherapy in Combination with Recombinant Vaccinia Boost and PD-1 Antibody.
Peng S; Ferrall L; Gaillard S; Wang C; Chi WY; Huang CH; Roden RBS; Wu TC; Chang YN; Hung CF
mBio; 2021 Jan; 12(1):. PubMed ID: 33468698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]